Following a recent article published by World Trademark Review (WTR) on an important Argentine ruling concerning trade dress and packaging protection, which includes the opinion of our partner Celia Lerman, we hereby present some of the main aspects of the decision and its practical impact for companies.
In another significant step toward a more innovation-friendly patent framework in Argentina, on June 19, 2026, the Argentine Patent and Trademark Office (INPI) repealed the biotechnology patentability guidelines that had been in force since 2015.
We are pleased to share that our partner Celia Lerman participated as a co-author of the 2025 edition of the IP Law Firms of the Future Think Tank report, an initiative of the International Trademark Association (INTA) that explores how intellectual property law firms are expected to evolve in response to the technological, economic, and regulatory changes reshaping the profession.
We are proud to share that our partner Celia Lerman has been included in the 2026 edition of WTR Global Leaders, a ranking that brings together some of the most distinguished trademark professionals worldwide.
Following a four-month research process, Leaders League published its 2026 rankings for Argentina. In this edition, Lerman & Szlak was recognized across several practice areas, with a standout “Excellent” ranking in Data Protection, alongside recognitions in Innovation, Technology and Intellectual Property.
IAM Patent 1000 has published its 2026 edition, and we are pleased to share that both our Firm and the members of our Patent team have been recognized in this year's rankings.
INPI Resolution 162/2026 published on May 29, 2026, established a new Regulation for the Recordal of Assignments and Titleholders' Changes of Name in trademarks, patents and industrial designs. The reform seeks to simplify procedures, modernize criteria and provide greater legal predictability to recordal operations before the Office.
The patentability guidelines for pharmaceutical inventions in force since 2012 and recently repealed as a consequence of the agreement between Argentina and the United States, had been judicially challenged by the chamber representing innovative pharmaceutical laboratories in Argentina (CAEMe) in the case “Cámara Argentina de Especialidades Medicinales y Otros c/ Estado Nacional Ministerio de Industria De La Nación y Otros s/ Nulidad De Acto Administrativo”, File No. 4960/2013.
As of May 1, 2026, official fees before the Argentine National Institute of Industrial Property (INPI) began to be updated monthly based on inflation through the new UMAPI system, replacing a relatively static fee structure. This change introduces a more dynamic approach to the management of trademarks and other intangible assets, where planning and strategic monitoring are becoming increasingly important.
